Deep-Dive Due Diligence AI Generated Report on China SXT Pharmaceuticals, Inc. Ordinary Shares (SXTC)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
15
$0.85
10
Speculative
Bearish
Earnings report
C
pharmaceuticals, bear market, high volatility
China SXT Pharmaceuticals Faces Steep Declines Amid Market Challenges
SXTC_OUT_1 [2025-04-17 09:54:02 -0400] 4185 Bytes | 1083 tokens | Cum: 1083 tkns (13.54% of 8k)
==========================================================================
We need a winner today and it's already 9:54:01 AM on Thu Apr 17, 2025 -0400 ... So let's find out if China SXT Pharmaceuticals (SXTC) is going up or if it's going nowhere fast. So, I pulled together a bunch of data for you to look over real fast. It's at 1.3325 up from 0.9889. Is there something here we can get excited about? Help me analyze.
--- COMPANY PROFILE ---
Company: China SXT Pharmaceuticals (SXTC)
IPO: 2019-01-04 (6 Years Ago)
Market Cap: $38,124,252
Shares Outstanding: 13,760,000
Exchange: XNAS
Description: China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Here’s a list of headlines for China SXT Pharmaceuticals:
Mar-17-25 08:30AM - China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency
Feb-21-25 12:35PM - China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Oct-07-24 04:15PM - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Oct-26-23 04:05PM - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule
Oct-04-23 08:30AM - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
Aug-02-23 06:03AM - China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)
May-10-23 08:00AM - China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
Mar-29-23 09:43AM - Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop
Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.
B1 - 2025-02-21T17:35:00Z - China SXT Pharmaceuticals, Inc. Announces Share Consolidation
B2 - 2024-07-12T09:35:41Z - Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
B3 - 2024-04-17T17:36:19Z - Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B4 - 2024-04-17T10:13:57Z - Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
B5 - 2024-04-16T18:17:57Z - Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B6 - 2024-01-02T18:35:24Z - Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
==============
-> THE ROLE FOR AI:
==============
1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for China SXT Pharmaceuticals (SXTC).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.
2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.
3) You will request information by referencing documents by their code.
4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.
5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.
NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`
SXTC_IN_2 [2025-04-17 09:54:02 -0400] 2 Bytes | 2 tokens | Cum: 1085 tkns (13.56% of 8k)
==========================================================================
B1
SXTC_OUT_3 [2025-04-17 09:54:03 -0400] 787 Bytes | 218 tokens | Cum: 1303 tkns (16.29% of 8k)
==========================================================================
Showing B1 (chunk 1 of 1): B1:
**China SXT Pharmaceuticals, Inc. Announces Share Consolidation**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/02/21/3030608/0/en/China-SXT-Pharmaceuticals-Inc-Announces-Share-Consolidation.htmlChina SXT Pharmaceuticals, Inc. (SXTC) announced a 1-for-8 share consolidation to regain compliance with the Nasdaq's minimum bid price requirement of $1.00 per share. The company's shares will begin trading on a post-consolidation basis on February 25, 2025.
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
SXTC_IN_4 [2025-04-17 09:54:03 -0400] 3 Bytes | 2 tokens | Cum: 1305 tkns (16.31% of 8k)
==========================================================================
NEX
SXTC_OUT_5 [2025-04-17 09:54:04 -0400] 1023 Bytes | 303 tokens | Cum: 1608 tkns (20.10% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-04-17T12:09:34Z - 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Forian (NASDAQ:FORA), Channel Therap...
A2 - 2025-04-16T21:05:42Z - 12 Health Care Stocks Moving In Wednesday's After-Market Session - Aspira Womens Health (NASDAQ:AWH)...
A3 - 2025-04-16T17:06:28Z - 12 Health Care Stocks Moving In Wednesday's Intraday Session - Biomerica (NASDAQ:BMRA), Acrivon Ther...
A4 - 2025-04-16T12:07:22Z - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Adaptive Biotechnologies (NASDAQ:AD...
A5 - 2025-04-03T20:01:23Z - SXTC stock plunges to 52-week low at $2.4 amid steep annual decline By Investing.com...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
SXTC_IN_6 [2025-04-17 09:54:04 -0400] 2 Bytes | 2 tokens | Cum: 1610 tkns (20.12% of 8k)
==========================================================================
A1
SXTC_OUT_7 [2025-04-17 09:54:05 -0400] 1181 Bytes | 348 tokens | Cum: 1958 tkns (24.47% of 8k)
==========================================================================
Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Thursday's Pre-Market Session - Forian (NASDAQ:FORA), Channel Therapeutics (AMEX:CHRO)**Date: 2025-04-17Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44861498/12-health-care-stocks-moving-in-thursdays-pre-market-sessionGainers Channel Therapeutics CHRO stock increased by 86.5% to $2.34 during Thursday's pre-market session. The market value of their outstanding shares is at $14.1 million. Sharps Technology STSS stock rose 34.33% to $0.04. InnovAge Holding INNV stock increased by 19.71% to $3.4. The market value of their outstanding shares is at $459.8 million. Quoin Pharmaceuticals QNRX stock increased by 19.35% to $7.16. The market value of their outstanding shares is at $147.4 million. Sunshine Biopharma SBFM shares rose 14.75% to $1.4. The market value of their outstandin
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
SXTC_IN_8 [2025-04-17 09:54:05 -0400] 3 Bytes | 2 tokens | Cum: 1960 tkns (24.50% of 8k)
==========================================================================
MOR
SXTC_OUT_9 [2025-04-17 09:54:05 -0400] 1181 Bytes | 345 tokens | Cum: 2305 tkns (28.81% of 8k)
==========================================================================
Showing A1 (chunk 2 of 3): g shares is at $5.0 million. China SXT Pharmaceuticals SXTC shares rose 14.25% to $1.13. The company's market cap stands at $15.5 million. Losers Forian FORA shares fell 36.0% to $1.26 during Thursday's pre-market session. The market value of their outstanding shares is at $39.3 million. TNF Pharmaceuticals TNFA shares decreased by 23.9% to $0.19. As per the news, the Q4 earnings report came out 4 days ago. Sophia Genetics SOPH stock declined by 19.58% to $2.26. The company's market cap stands at $150.1 million. UnitedHealth Group UNH stock declined by 19.33% to $472.0. The company's market cap stands at $431.7 billion. As per the press release, Q1 earnings came out today. Tourmaline Bio TRML shares declined by 15.98% to $12.2. The company's market cap stands at $313.3 million. enVVeno Medical NVNO shares declined by 15.13% to $2.02. The company's market cap stands at $35.4 million. See
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
SXTC_IN_10 [2025-04-17 09:54:05 -0400] 3 Bytes | 2 tokens | Cum: 2307 tkns (28.84% of 8k)
==========================================================================
MOR
SXTC_OUT_11 [2025-04-17 09:54:06 -0400] 1097 Bytes | 353 tokens | Cum: 2660 tkns (33.25% of 8k)
==========================================================================
Showing A1 (chunk 3 of 3): Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CHROChannel Therapeutics Corp$2.3788.8%Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock - anytime.
Reveal Full ScoreEdge RankingsMomentum73.30Price TrendShortMediumLongOverviewFORAForian Inc$1.25-36.5%INNVInnovAge Holding Corp$3.2012.7%NVNOenVVeno Medical Corp$2.02-15.1%QNRXQuoin Pharmaceuticals Ltd$6.6811.3%SBFMSunshine Biopharma Inc$1.230.82%SOPHSophia Genetics SA$2.25-19.9%STSSSharps Technology Inc$0.036537.7%SXTCChina SXT Pharmaceuticals Inc$1.1011.2%TNFATNF Pharmaceuticals Inc$0.1936-21.2%TRMLTourmaline Bio Inc$12.20-16.0%UNHUnitedHealth Group Inc$473.00-19.1%Market News and Data brought to you by Benzinga APIs
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
SXTC_IN_12 [2025-04-17 09:54:06 -0400] 3 Bytes | 2 tokens | Cum: 2662 tkns (33.27% of 8k)
==========================================================================
NEX
SXTC_OUT_13 [2025-04-17 09:54:08 -0400] 238 Bytes | 59 tokens | Cum: 2721 tkns (34.01% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
SXTC_IN_14 [2025-04-17 09:54:08 -0400] 15 Bytes | 3 tokens | Cum: 2724 tkns (34.05% of 8k)
==========================================================================
It appears that
SXTC_OUT_15 [2025-04-17 09:54:08 -0400] 251 Bytes | 78 tokens | Cum: 2802 tkns (35.02% of 8k)
==========================================================================
You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source
You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.
SXTC_IN_16 [2025-04-17 09:54:08 -0400] 13 Bytes | 3 tokens | Cum: 2805 tkns (35.06% of 8k)
==========================================================================
It seems like
SXTC_OUT_17 [2025-04-17 09:54:21 -0400] 4999 Bytes | 1191 tokens | Cum: 3996 tkns (49.95% of 8k)
==========================================================================
This is our set of metrics for China SXT Pharmaceuticals.
Please analyze the numbers.
+---------------------+-----------------------+------------------------+----------------------+
| Volume: 247,498 | Perf Month: -57.14% | Option/Short: No / Yes | Sales Y/Y TTM: 6.78% |
+---------------------+-----------------------+------------------------+----------------------+
| Avg Volume: 135.10K | Perf Quarter: -65.09% | Short Float: 0.38% | ROE: 57.63% |
+---------------------+-----------------------+------------------------+----------------------+
| Rel Volume: 26.36 | Index: - | Short Ratio: 0.39 | ROI: 37.79% |
+---------------------+-----------------------+------------------------+----------------------+
| RSI (14): 30.25 | Market Cap: 15.76M | Short Interest: 0.05M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+----------------------+
| ATR (14): 0.41 | Shs Outstand: 13.76M | Beta: 1.49 | EPS Surprise: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA20: -53.00% | Shs Float: 13.73M | Sales Q/Q: - | P/E: 0.42 |
+---------------------+-----------------------+------------------------+----------------------+
| SMA50: -63.49% | Inst Own: 0.01% | Sales past 5Y: -19.85% | Earnings: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA200: -75.71% | Insider Own: 0.27% | Employees: 75 | |
+---------------------+-----------------------+------------------------+----------------------+
| Perf Week: -56.96% | Insider Trans: 0.00% | Debt/Eq: 0.16 | |
+---------------------+-----------------------+------------------------+----------------------+
The next section covers any insider trading by China SXT Pharmaceuticals officers or majority shareholders (if available).
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 1.33
Average Volume: 79399.09
30-Day High: 3.08
30-Day Low: 0.9889
No detailed financial data available.
==== END OF FINANCIAL REPORT ====
You are now requested to write a summary analysis of China SXT Pharmaceuticals (SXTC).
Please complete the report using the exact format:
FIELD[value]
1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about China SXT Pharmaceuticals.
2) MARKET_SCORE[]
This conversation was initiated because SXTC is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for SXTC.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.
3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, SXTC could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect SXTC to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]
4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.
5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.
6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)
7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.
8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.
9) SENTIMENT[]
bullish, bearish, neutral, or mixed
10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of China SXT Pharmaceuticals.
11) ETHICAL_RATING[]
Rate China SXT Pharmaceuticals’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.
12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of China SXT Pharmaceuticals.
Provide any reasons you can use to support it.
Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.
Finally, thank you for participating!
SXTC_IN_18 [2025-04-17 09:54:21 -0400] 1150 Bytes | 240 tokens | Cum: 4236 tkns (52.95% of 8k)
==========================================================================
BRIEF_SUMMARY[China SXT Pharmaceuticals has experienced significant negative stock performance with a steep decline in both short and long-term moving averages, signaling strong bearish trends. Despite a relatively healthy ROE and ROI, the substantial drop in market cap, along with poor performance metrics over the month, quarter, and year, suggest investor confidence may be low. The company's sales growth Y/Y and a low P/E ratio could indicate some underlying value, but the overall market sentiment seems negative.]
MARKET_SCORE[15]
PRICE_TARGET[0.85]
AI_RPT_HEADLINE[China SXT Pharmaceuticals Faces Steep Declines Amid Market Challenges]
SQUEEZE_POTENTIAL[10]
TAGS[pharmaceuticals, bear market, high volatility]
STOCK_TYPE[speculative]
PRIMARY_CATALYST[earnings report]
SENTIMENT[bearish]
IMPROVEMENT_SUGGESTION[Detailed current financial statements including revenue, net income, and total assets and liabilities would enhance the analysis.]
ETHICAL_RATING[C]
UPCOMING_CATALYST[Next quarterly earnings report could significantly impact stock price due to current volatility and investor sensitivity to company performance metrics.]
SXTC_IN_19 [2025-04-17 09:54:22 -0400] 126 Bytes | 29 tokens | Cum: 4265 tkns (53.31% of 8k)
==========================================================================
====================================
[2025-04-17 09:54:22] # Analysis Completed
Elapsed Time: 21.07 seconds